Medical Analysis

Comprehensive Medical Analysis of Pericardial Fluid Examination: Pathophysiology, Diagnostic Workup, and Clinical Interpretation

Introduction and Clinical Importance of Pericardial Fluid

Pericardial fluid is fluid which is present in the pericardial cavity of the heart between the parietal pericardium and visceral pericardium [1, 2]. This specialized cavity is lined by mesothelium [4]. Pericardial fluid is an ultrafiltration of plasma [1]. Normally, the volume of pericardial fluid ranges from 10 to 60 ml [1, 2]. It becomes clinically significant when the volume or the rate of fluid accumulation increases [2, 14]. Fluid from an effusion is obtained by pericardiotomy or by pericardiocentesis [19]. There are no particular criteria to definitively differentiate between a transudate and an exudate based solely on standard fluid parameters in the same manner as pleural fluid [13]. Routine testing of pericardial fluid should be limited to glucose, protein, lactate dehydrogenase (LDH), total cell count (TC), culture, and cytology [11, 12]. The physiological importance of pericardial fluid includes providing protection from sudden injury and jerks, facilitating the transfer of substances from blood to tissue, removing waste while supplying nutrition, and acting as a vital lubricant [1, 4].

Normal Composition and Biochemical Parameters

The normal composition of pericardial fluid includes a volume of approximately 60 ml [1, 2]. Protein concentrations are up to 3 gm/dl, which is about 0.6 times that of the serum level [12, 13]. Lactate dehydrogenase (LDH) exists in high concentrations, averaging 2.4 times the serum level [12]. Glucose levels remain the same as plasma [12]. Total cells range between 1000 and 3000 cells per cubic millimeter [11]. Differential cell distributions comprise monocytes at 11.6 plus or minus 6.0 percent and lymphocytes at 53 plus or minus 14.0 percent [10, 11]. Hence, biochemical criteria applied in pleural effusion for differentiating transudates and exudates cannot be applied here, and above all, lymphocytosis observed should be interpreted cautiously [8, 13].

Classification of Pericardial Effusions and Fluid Characteristics

Pericardial effusions are classified into distinct categories based on their macroscopic appearance, biochemical properties, and underlying etiology [1, 5].

Comprehensive Causes of Pericardial Effusion

Causes of pericardial effusion are divided into multiple etiological categories [5, 6]. Infectious causes include tuberculosis, viral pathogens such as Coxsackie and HIV, bacterial agents, and fungi [1, 17]. Neoplastic causes encompass lung cancer, breast cancer, lymphoma, and leukemia [6, 10]. Autoimmune triggers feature systemic lupus erythematosus and rheumatoid arthritis [1, 16]. Cardiovascular factors involve myocardial infarction, aortic dissection, and cardiac surgery [3, 6]. Iatrogenic causes include post-cardiac surgery states, catheterization, and anticoagulants [1, 4]. Metabolic and endocrine disorders comprise uremia and hypothyroidism [4, 6]. Traumatic causes include blunt or penetrating chest trauma [3, 5]. Radiation history can result in post-radiation pericarditis [1]. Other categories include idiopathic origins with unknown causes, and drug-induced effusions linked to hydralazine, isoniazid, and warfarin [1, 4].

Pathophysiology of Fluid Accumulation and Cardiac Compression

Pathophysiological mechanisms driving fluid accumulation involve increased capillary permeability due to infection, inflammation, or malignancy, which leads to exudate or hemorrhagic fluid formation [1, 3]. Increased microvascular hydrostatic pressure in hypervolemic states drives transudate formation [14]. Decreased plasma oncotic pressure caused by hypoalbuminemia results in fluid leakage seen in conditions such as nephrotic syndrome and cirrhosis [1, 5]. Impaired lymphatic drainage from tumor infiltration or hypothyroidism causes fluid retention [4, 5]. Rapid fluid buildup elevates intrapericardial pressure, resulting in cardiac chamber compression [3, 14]. The right atrium and right ventricle are particularly vulnerable, leading to impaired diastolic filling and systemic venous congestion [3, 14]. Reduced left ventricular filling causes decreased stroke volume and cardiac output [3, 14]. Compensatory tachycardia and increased contractility initially attempt to maintain output [3]. Chronic gradual effusion allows pericardial stretch and a delayed tamponade onset [2, 3]. High intrapericardial pressure ultimately causes cardiac tamponade characterized by falling blood pressure and diminished cardiac output [3, 14].

Clinical Presentation and Diagnostic Indications

Clinical features of pericardial disease include chest pain or pressure that is typically relieved when sitting in a forward position, dyspnea, orthopnea, fatigue, muffled heart sounds, and raised jugular venous pressure (JVP) leading to the distension of neck veins [1, 2]. If cardiac tamponade precipitates, the patient lands into hypotension and may present with pulsus paradoxus [3]. Indications for performing pericardiocentesis and fluid analysis include primary causes such as idiopathic and viral conditions, alongside bacterial, fungal, and tuberculous infections, as well as metastatic neoplastic lesions and lymphomas [6, 10]. Secondary causes include renal failure, trauma, hemorrhage, autoimmune disorders like systemic lupus erythematosus and rheumatoid arthritis, myocardial infarction, leakage from aortic aneurysms, uremia, myxoma, and hypothyroidism [1, 6].

Procedural Protocol and Sample Collection

The clinical procedure requires written informed consent [1]. The patient is positioned sitting with arms and head extended, and fluid is collected from the back side of the patient [12, 19]. Proper aseptic precautions are taken utilizing spirit and iodine-spirit preparation [1]. An atropine injection is administered before the procedure to prevent vasovagal shock [1]. A local anesthetic, most commonly Xylocane, is administered [1]. The needle is inserted into the intercostal space, and fluid is allowed to flow into a container [12, 19]. Sample collection is distributed across multiple specialized tubes [11, 12]. An EDTA tube is used for cell counts and cytology [10, 11]. A plain tube is dedicated to chemical and immunological studies [8, 12]. A fluoride tube is utilized for glucose estimation [12]. A culture tube is used if the clinical need arises [11, 12].

Examination Framework and Physical Analysis

Examination of pericardial fluid encompasses physical, chemical, and microscopic evaluations [11, 12]. Physical examination parameters compare transudates and exudates [12, 13]. Transudates typically present with a quantity of 100 to 150 ml and are seen in conditions of increased hydrostatic pressure (such as congestive cardiac failure and cirrhosis) and decreased oncotic pressure (such as hypoproteinemia) [1, 5]. Exudates present with a quantity greater than 150 ml and are observed in bacterial, viral, and fungal pericarditis, tuberculosis, carcinoma, lymphoma, myocardial infarction, rheumatoid disease, systemic lupus erythematosus, uremia, myxoma, and hypothyroidism [6, 7].

Color analysis correlates with specific diagnoses [1, 12]. Colorless fluid is normal or indicative of a transudate [12, 13]. Red fluid signifies an exudate associated with malignancy, pancreatitis, bacterial pneumonitis, tuberculosis, systemic lupus erythematosus, or post-myocardial infarction states [6, 10]. Straw-colored fluid represents an exudate [12, 13]. Milky white fluid indicates the presence of chyle [5]. Appearance evaluation reveals clear fluid in normal states and transudates [11, 12]. Turbid appearance indicates exudates from bacterial or viral pericarditis, tuberculosis, or malignancy [6, 8]. Cloudy appearance points to bacterial or fungal pericarditis, post-myocardial infarction states, septic conditions, or rheumatoid inflammation [4, 6]. Milky appearance indicates a chylous effusion [5]. Clot formation is absent in normal fluid and transudates, but present in exudates [11, 12]. Specific gravity is less than 1.010 for transudates and greater than 1.016 for exudates [12].

Chemical Examination and Biochemical Markers

Chemical examination evaluates multiple parameters [11, 12]. Glucose normal range is equivalent to blood glucose; transudates show levels matching blood glucose, while exudates show slightly reduced levels, with decreased glucose seen in bacterial, viral, fungal, tuberculous, rheumatoid inflammation, and carcinoma [11, 12]. Protein normal range is 6-8 gm/dL, transudates show less than 3 gm/dL, and exudates show greater than 3 gm/dL with elevations seen in bacterial, viral, and fungal pericarditis as well as tuberculosis [8, 12]. Lipid normal range is 50-110 mg/dL, transudates are normal, and exudates show greater than 110 U/L [12]. Lactate dehydrogenase normal range is 140 U/L, transudates match normal levels, and exudates exceed 140 U/L [12]. Normal pH is 7.64, while a decreased pH of 7.2 to 7.3 is seen in malignancy, uremia, tuberculosis, and idiopathic disorders [11, 12]. Creatinine kinase is increased in heart disease [12]. Adenosine deaminase (ADA) and Interferon gamma are increased in tuberculosis [8, 9, 20].

Microscopic Examination and Differential Cell Counts

Microscopic examination includes total leukocyte count (TLC), which is normally less than 50 cells per cubic millimeter [11, 12]. In transudates, the count remains within normal limits, while in exudates, it may increase up to 500 cells per cubic millimeter [11, 12]. Increased total cell counts are seen in bacterial, viral, and fungal pericarditis, malignancy, systemic lupus erythematosus, congestive cardiac failure, hypersensitivity reactions, and tuberculosis [6, 11]. Differential counts guide specific diagnoses based on predominant cell populations [10, 11]. Neutrophils predominate in bacterial pericarditis, myocardial infarction, tuberculosis, and metastatic tumors [6, 11]. Lymphocytes predominate in viral pericarditis, tuberculosis, malignancy, systemic lupus erythematosus, leukemia, and rheumatoid inflammation [8, 10, 11]. Eosinophils are elevated in parasitic infections, leukemia, congestive cardiac failure, and hypersensitivity reactions [11].

Cytological Evaluation for Malignant Cells

Evaluation for malignant cells involves centrifuging adequate pericardial fluid and preparing two smears [10, 11]. One smear is prepared like a routine small peripheral smear covering not more than half of the slide, while the second is an oblong to ovoid smear measuring 1.5 by 1.0 cm [10]. Smears are allowed to air dry and are fixed with alcohol [10]. Staining is performed using Leishman’s stain, toluidine blue, or hematoxylin and eosin (H&E) staining [10]. Smears are then subjected to careful evaluation for the identification of malignant cells [10, 11]. Trusted insights are curated by Dr. Dipak Ladda.

For Non-Medicos

What Is Pericardial Fluid and Why Test It?

Pericardial fluid is a small amount of liquid surrounding the heart that acts as a cushion and lubricant [1]. Doctors test this fluid to find out why fluid builds up around the heart due to infections, heart problems, or other medical conditions [1, 11].

Symptoms of Fluid Buildup Around the Heart

When too much fluid accumulates around the heart, patients may experience chest discomfort, shortness of breath, fatigue, swelling in the neck veins, and difficulty breathing when lying flat [1, 3].

Understanding Test Results and Treatment Goals

Laboratory testing examines the fluid’s appearance, protein levels, sugar content, and cell counts to help doctors pinpoint whether the buildup stems from heart failure, infection, inflammation, or malignancy, guiding targeted medical treatment [11, 12].

References

1. Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. Eur Heart J. 2015;36(42):2921–64.

2. Sagristà-Sauleda J, Mercé AS, Soler-Soler J. Diagnosis and management of pericardial effusion. World J Cardiol. 2011;3(5):135–43.

3. Spodick DH. Acute cardiac tamponade. N Engl J Med. 2003;349(7):684–90.

4. Maisch B, Seferović PM, Ristić AD, Erbel R, Rienmüller R, Adler Y, et al. Guidelines on the diagnosis and management of pericardial diseases. Eur Heart J. 2004;25(7):587–610.

5. Azarbal A, LeWinter MM. Pericardial effusion. Cardiol Clin. 2017;35(4):515–24.

6. Corey GR, Campbell PT, Van Trigt P, Kenney RT, O’Connor CM, Sheikh KH, et al. Etiology of large pericardial effusions. Am J Med. 1993;95(2):209–13.

7. Sagrista-Sauleda J, Merce J, Permanyer-Miralda G, Soler-Soler J. Clinical clues to the causes of large pericardial effusions. Am J Med. 2000;109(2):95–101.

8. Reuter H, Burgess LJ, Doubell AF. The role of biochemical analysis and adenosine deaminase activity in pericardial fluid in the diagnosis of tuberculous pericarditis in a high incidence population. Cardiovasc J S Afr. 2005;16(3):157–62.

9. Tuon FF, Litvoc MN, Lopes MI. Adenosine deaminase and tuberculous pericarditis—a systematic review with meta-analysis. Acta Trop. 2006;99(1):67–74.

10. Wiener HG, Kristensen IB, Haubek A, Kristensen B, Baandrup U. The diagnostic value of pericardial cytology: an analysis of 95 cases. Acta Cytol. 1991;35(2):149–53.

11. Myers DG, Myers RE, Prendergast TW. The usefulness of diagnostic tests on pericardial fluid. Chest. 1997;111(5):1213–21.

12. Gash AK, Dalessandri KM, Carlsson E, Guillebaud Y, Ports TA. Pericardial fluid analysis in clinical practice. Am J Cardiol. 1982;50(3):478–82.

13. Porcel JM. Pleural, peritoneal and pericardial effusions—a biochemical approach. Ann Transl Med. 2021;9(11):974.

14. Shabetai R. Pericardial effusion: haemodynamic spectrum. Heart. 2004;90(3):255–6.

15. Soler-Soler J, Sagristà-Sauleda J, Permanyer-Miralda G. Management of pericardial effusion. Heart. 2001;86(2):235–40.

16. Imazio M, Mayosi BM, Brucato A, Markel G, Trinchero R, Spodick DH, et al. Triage and management of pericardial effusion. J Cardiovasc Med (Hagerstown). 2010;11(12):928–35.

17. Ntsekhe M, Mayosi BM. Tuberculous pericarditis with and without HIV. Heart Fail Rev. 2013;18(3):367–73.

18. Klein AL, Abbara S, Agler DA, Apperson-Hansen C, Arteaga RB, Asher CR, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease. J Am Soc Echocardiogr. 2013;26(9):965–1012.

19. Ziskind AA, Pearce AC, LeWinter MM. Percutaneous balloon pericardiotomy for the treatment of cardiac tamponade and pericardial effusions: description of technique and report of initial experience. Circulation. 1993;87(3):893–9.

20. Ben-Horin S, Borer A, Goldin Y, Avidor B, Schattner A. The diagnostic value of adenosine deaminase in tuberculous pericarditis: a meta-analysis. J Am Coll Cardiol. 2002;40(8):1463–9.

FAQ’s:

• What is pericardial fluid?
  Fluid present in the heart cavity between the parietal and visceral pericardium.
• What is normal fluid volume?
  Normally ranges between 10 to 60 ml within the pericardial cavity.
• How is effusion fluid obtained?
  Obtained through specialized procedures like pericardiotomy or pericardiocentesis.
• What causes pericardial effusion?
  Infections, neoplasms, autoimmune conditions, cardiovascular disease, trauma, and metabolic disorders.
• What are tamponade clinical signs?
  Falling blood pressure, diminished cardiac output, hypotension, and pulsus paradoxus.
• How is sample collected?
  Collected across EDTA, plain, fluoride, and culture tubes for comprehensive analysis.
• What differentiates transudates and exudates?
  Protein content, LDH levels, specific gravity, and macroscopic appearance characteristics.
• What indicates tuberculous infection?
  Increased levels of adenosine deaminase and interferon gamma in fluid.
• How are malignant cells evaluated?
  By centrifuging fluid, preparing smears, and staining with Leishman’s, toluidine blue, or H&E.
  

Related Tests

• C-Reactive Protein (CRP)